China
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
50.49%
|
Dec. 31, 2023 | USD 7.29 | NA |
|
China |
|
2 |
35.74%
|
Dec. 31, 2023 | USD 0.16 | -0.86% |
|
China |
|
3 |
27.08%
|
Dec. 31, 2023 | USD 3.10 | -2.67% |
|
China |
|
4 |
25.01%
|
Dec. 31, 2023 | USD 0.61 | NA |
|
China |
|
5 |
24.45%
|
Dec. 31, 2023 | USD 0.32 | 3.25% |
|
China |
|
6 |
18.46%
|
March 31, 2024 | USD 0.31 | -5.19% |
|
China |
|
7 |
18.43%
|
Dec. 31, 2023 | USD 1.35 | NA |
|
China |
|
8 |
18.25%
|
Dec. 31, 2023 | USD 1.65 | NA |
|
China |
|
9 |
12.06%
|
Dec. 31, 2023 | USD 0.49 | 2.08% |
|
China |
|
10 |
10.46%
|
Dec. 31, 2023 | USD 6.74 | -3.81% |
|
China |
|
11 |
2.81%
|
Dec. 31, 2023 | USD 0.68 | NA |
|
China |
|
12 |
-25.23%
|
Dec. 31, 2023 | USD 1.40 | NA |
|
China |
The Dental Care company in China with the highest EBITDA Margin is Giant Biogene Holding Co., Ltd. (HKSE: 2367.HK) at 50.49%.
The Dental Care company in China with the lowest EBITDA Margin is Zhongchao Inc. (NasdaqCM: ZCMD) at -25.23%.
The top 10 Dental Care companies in China by EBITDA Margin are Giant Biogene Holding Co., Ltd., Rici Healthcare Holdings Limited, Shanghai Haohai Biological Technology Co., Ltd., Genertec Universal Medical Group Company Limited, Jinxin Fertility Group Limited, Arrail Group Limited, China Isotope & Radiation Corporation, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., China Resources Medical Holdings Company Limited and Angelalign Technology Inc..
The bottom 10 Dental Care companies in China by EBITDA Margin are Zhongchao Inc., Yunkang Group Limited, Angelalign Technology Inc., China Resources Medical Holdings Company Limited, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., China Isotope & Radiation Corporation, Arrail Group Limited, Jinxin Fertility Group Limited, Genertec Universal Medical Group Company Limited and Shanghai Haohai Biological Technology Co., Ltd..